Normunity Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 23

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $75M

  • Investors
  • 11

Normunity General Information

Description

Operator of a biotechnology company intended to create precision immuno-oncology medicines. The company's medicine drives the exclusion of T-cells from immune-sensitive tumors and other mechanisms that are barriers to normal immune function, enabling doctors to treat cancer by restoring the state of normal immunity.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 101 College Street
  • New Haven, CT 06510
  • United States
+1 (203)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 101 College Street
  • New Haven, CT 06510
  • United States
+1 (203)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Normunity Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series B) 24-Sep-2025 $75M Completed Clinical Trials - Phase 1
2. Early Stage VC (Series A) 25-Oct-2022 Completed Pre-Clinical Trials
1. Seed Round 11-Jan-2022 $42.1M $42.1M Completed Startup
To view Normunity’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Normunity Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology company intended to create precision immuno-oncology medicines. The company's medicine drive
Drug Discovery
New Haven, CT
23 As of 2026

Paris, France
 

Paris, France
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Normunity Competitors (17)

One of Normunity’s 17 competitors is Enterome, a Venture Capital-Backed company based in Paris, France.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Enterome Venture Capital-Backed Paris, France
Eligo Bioscience Venture Capital-Backed Paris, France
Vedanta Biosciences Venture Capital-Backed Cambridge, MA
4D pharma Corporation Leeds, United Kingdom
Seres Therapeutics Formerly VC-backed Cambridge, MA
You’re viewing 5 of 17 competitors. Get the full list »

Normunity Patents

Normunity Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026090139-A1 Anti-ly6k antibody-drug conjugates and methods of use Pending 21-Oct-2024
WO-2026039453-A1 Anti-klk6 antibodies and methods of use Pending 12-Aug-2024
EP-4820379-A2 Anti-ly6k antibodies and methods of use Pending 04-Dec-2023
WO-2025122587-A2 Anti-ly6k antibodies and methods of use Inactive 04-Dec-2023
WO-2025122587-A3 Anti-ly6k antibodies and methods of use Inactive 04-Dec-2023 C07K16/28
To view Normunity’s complete patent history, request access »

Normunity Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Normunity Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Enavate Sciences Venture Capital Minority
HSG (Hong Kong) Venture Capital Minority
Pfizer Ventures Corporate Venture Capital Minority
Regeneron Ventures Corporate Venture Capital Minority
Samsara BioCapital Venture Capital Minority
You’re viewing 5 of 11 investors. Get the full list »

Normunity FAQs

  • When was Normunity founded?

    Normunity was founded in 2020.

  • Where is Normunity headquartered?

    Normunity is headquartered in New Haven, CT.

  • What is the size of Normunity?

    Normunity has 23 total employees.

  • What industry is Normunity in?

    Normunity’s primary industry is Drug Discovery.

  • Is Normunity a private or public company?

    Normunity is a Private company.

  • What is Normunity’s current revenue?

    The current revenue for Normunity is .

  • How much funding has Normunity raised over time?

    Normunity has raised $182M.

  • Who are Normunity’s investors?

    Enavate Sciences, HSG (Hong Kong), Pfizer Ventures, Regeneron Ventures, and Samsara BioCapital are 5 of 11 investors who have invested in Normunity.

  • Who are Normunity’s competitors?

    Enterome, Eligo Bioscience, Vedanta Biosciences, 4D pharma, and Seres Therapeutics are some of the 17 competitors of Normunity.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process